Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

drug-trials

MultiOmic Health and BIO4 Campus sign collaborative Memorandum of Understanding

September 8, 2025 Medical Communications, Research and Development AI, BIO4 Campus, Memorandum of Understanding, MultiOmic Health, biotech

MultiOmic Health (MOH), an artificial intelligence (AI)-enabled precision medicine biotechnology company and BIO4 Campus (BIO4), a biotechnology and life sciences …
News

Rare and severe epilepsies – current treatments and advance therapeutics

August 29, 2025 Medical Communications, Research and Development Neurology, UCB, epilepsy, epilepsy treatment, rare epilepsies

The current forms of immunotherapy, how T cell therapy works and what the future holds
Feature
hospital

The Pharma Files: With Professor Hatim Abdulhussein from Health Innovation Kent Surrey Sussex

August 28, 2025 Medical Communications, Research and Development Corporate, GP, Health Innovation Kent Surrey Sussex, The Pharma Files

Pharmafile chats with Priyanka Hinton, Customer Solutions Director at Chase People about the best parts of her job and her …
Feature

European Commission approves HIV prevention injection

August 28, 2025 Medical Communications, Research and Development European Commission, Gilead Science, HIV, HIV/AIDS, US Food and Drug Administration, World Health Organisation

The European Commission (EC) has granted marketing authorisation for Gilead Science’s Yeytuo (lenacapavir), the first twice-yearly injectable medicine approved in …
News

EMA grants orphan drug designation for Roca’s treatment of radiation maculopathy

August 28, 2025 Medical Communications, Research and Development European Medicines Agency (EMA), Oncology, Opthalmology, Roca Therapeutics, maculopathy

The European Medicines Agency (EMA) has granted Orphan Drug Designation to Roca Therapeutics for its lead candidate RCT002, marking the …
News

Neogap Therapeutics appoints Jonas Mattson to its board of directors

August 26, 2025 Research and Development Corporate, Immunology, Neogap Therapeutics, Oncology, board of directors

Swedish biotech, Neogap Therapeutics, has appointed Jonas Mattson, an authority in cell therapy, to its board of directors. His appointment …
Appointment
hsm_mobile_clinical_trial_istock-872676342

FDA approves Wegovy for treatment of MASH in adults with liver fibrosis

August 22, 2025 Medical Communications, Research and Development Hepatology, Novo Nordisk, US Food and Drug Administration, clinical trial, hepatitis, obesity

The US Food and Drug Administration (FDA) has granted accelerated approval for Wegovy (semaglutide) as a treatment for adults with …
News
epilepsy-623346_960_720

Epilepsy Research Institute opens 2025-26 grant round with new awards

August 21, 2025 Medical Communications, Research and Development Neurology, epilepsy, funding programme, medical research

The Epilepsy Research Institute has opened its 2025-26 Grant Round, offering a wide range of funding opportunities designed to support …
News

HUTCHMED completes enrolment in phase 3 trial for lung cancer

August 21, 2025 Research and Development HUTCHMED, Oncology, clinical trial, lung cancer, non-small cell lung cancer

HUTCHMED has completed patient enrolment for the SANOVO phase 3 clinical trial, investigating the use of ORPATHYS (savolitinib) in combination …
News

BioMed X and Novo Nordisk partner on oral peptide drug delivery innovation

August 19, 2025 Mergers and Acquisitions, Research and Development BioMed X, Novo Nordisk, Pharmacy, drug development, therapeutic peptides

BioMed X has announced a new collaboration with Novo Nordisk to improve oral delivery of therapeutic peptides – a major …
News
Lung cancer cells

Graphene-based biosensor to support new lung cancer screening test

August 18, 2025 Business Services, Research and Development Ease Healthcare, Hawkeye Bio, HydroGraph, Oncology, lung cancer

HydroGraph, a Canadian producer of ultra-pure graphene, has announced a partnership with Hawkeye Bio and Ease Healthcare to support the …
News
money-2180330_960_720

Anocca secures £32m to advance pancreatic cancer trial

August 18, 2025 Research and Development Anocca, Oncology, Pancreatic cancer, research funding

Swedish biopharma Anocca has raised approximately £32m (SEK 440m) to support the early-stage clinical development of VIDAR-1, its lead TCR-T …
News

FDA approves first new fibromyalgia therapy in over 15 years

August 18, 2025 Medical Communications, Research and Development Pain, Tonix Pharmaceutical, US Food and Drug Administration, chronic pain, clinical trial, fibromyalgia

The US Food and Drug Administration (FDA) has approved Tonix Pharmaceutical’s Tonmya (cyclobenzaprine hydrochloric acid) for the treatment of fibromyalgia …
News
Astra Zeneca Logo

NICE recommends Benralizumab for Rare Form of Vasculitis

August 15, 2025 Medical Communications, Research and Development AstraZeneca, Immunology, National Institute for Health and Care Excellence, vasculitis

The National Institute for Health and Care Excellence (NICE) has recommended AstraZeneca’s benralizumab (Fasenra) as an add-on treatment for adult …
News
drug-trials

Novartis candidate for Sjögren’s disease presents positive results

August 15, 2025 Research and Development Immunology, Novartis, Sjögren’s disease, US Food and Drug Administration, clinical trial

Novartis has reported positive results from two phase 3 clinical trials – NEPTUNUS-1 and NEPTUNUS-2 – evaluating ianalumab in adults …
News
The Gateway to Local Adoption Series

Latest content

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026